- Research article
- Open Access
Intraocular lens power calculation using standard formulas and ray tracing after DMEK in patients with Fuchs endothelial dystrophy
BMC Ophthalmology volume 17, Article number: 152 (2017)
The study presented here aims to optimize the accuracy of intraocular lens (IOL) power calculations in patients after DMEK by evaluation of the impact of the altered anterior/posterior corneal curvature relationship.
Scheimpflug-based Oculus Pentacam imaging was performed after DMEK surgery for Fuchs endothelial dystrophy. The IOL power was calculated for all patients by ray tracing, aiming for postoperative emmetropia. We also performed the IOL calculation using four third-generation formulas (SRK-T, Hoffer-Q, Holladay-1 and Haigis). The residual refractions for the individual target IOL were compared and analyzed.
This retrospective study included 42 eyes of 33 patients (age 68.73 ± 10.11 years) after DMEK surgery. The differences between the expected residual refraction based on ray tracing and that predicted with the third-generation formulas were statistically significant (all formulas p < 0.001). The highest mean difference in the residual refraction between the target IOL measured by ray tracing and that calculated with third-generation formulas was found for the Haigis formula (0.90 ± 0.40 D), and the lowest mean difference for the SRK/T formula (0.73 ± 0.49 D).
DMEK surgery induced a relevant change in the anterior to posterior corneal curvature relationship; this needs to be taken into account in the IOL power calculation to avoid hyperopic refractive surprises.
Fuchs endothelial dystrophy (FED) is a common disease requiring corneal transplantation. Patients with Fuchs endothelial dystrophy have been treated in the past with penetrating keratoplasty but over the last few years new surgical techniques of posterior lamellar keratoplasty have been introduced (Descemet stripping endothelial keratoplasty (DSEK), Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK)) [1, 2].
DMEK is the latest development in endothelial keratoplasty; with this procedure, damaged endothelial cells can be replaced using only donor Descemet’s membrane with endothelium . This allows faster visual rehabilitation, improved visual acuity and improved corneal transparency [2,3,4,5,6]. Refractive change after DMEK has been described as slight [7, 8], Ham et al. showing a refractive change in spherical equivalent at 6 months post DMEK of +0.32 ± 1.01 diopter . They propose that the hyperopic shift results from a reversal of a preceding myopic shift induced by stromal swelling in endothelial disease . In a previous study, our group demonstrated a significant change in the refractive power of the posterior surface of the cornea while the anterior cornea remained nearly unchanged .
DMEK can be performed in phakic eyes with a clear lens without performing lens-surgery [10, 11]. When these patients develop clinically significant cataract post DMEK, the changes on the posterior surface induced by surgery may be relevant for IOL power calculation. In FED patients, who have additional, clinically significant cataract and need simultaneous phacoemulsification, DMEK can be performed together with cataract surgery in the same session . A reliable IOL power calculation is also necessary in this situation.
The aim of this study is to evaluate the impact of the changed posterior corneal surface on IOL power calculation after DMEK.
Subjects and selection criteria
This retrospective study included 42 eyes of 33 patients who had undergone DMEK for FED at the Dept. of Ophthalmology, University of Münster Medical Center. The study was approved by the local ethics committee and adhered to the tenets of the Declaration of Helsinki.
Patients were examined using rotating Scheimpflug corneal and anterior segment tomography (Pentacam HR; Oculus, Wetzlar, Germany). All patients were examined after attaining refractive stability (minimum 3 months after surgery)  under the same conditions; the automatic release mode of the Pentacam was used to minimize examiner-induced errors and only Pentacam images of good quality (internal quality indicator of the Pentacam) were included. A skilled examiner performed the Pentacam imaging. Eyes with a history of trauma, corneal infection or intraocular inflammation, corneal scars, contact lens wear three weeks before measurement, clinically significant graft detachment or delayed corneal clearance were excluded.
IOL power calculation
To allow accurate quantification of the impact of the changed posterior corneal surface after DMEK surgery on the calculation of IOL power, we used a standard axial length of 23.6 mm, an anterior chamber depth (ACD) of 3.0 mm and pupil entrance diameter of 2.5 mm for all patients. Optimized IOL constants were used, as published on the “User Group for Laser Interference Biometry” website: (http://ocusoft.de/ulib/index.htm).
The refractive errors for all patients were determined using the OKULIX ray tracing software and we used the same IOL (Carl Zeiss CT Asphina 409 M) with individual IOL power aimed at a level close to emmetropia. The OKULIX software was developed at the University of Mainz and has been described in detail in various publications [13,14,15,16,17]. The corneal power in this context was measured by ray tracing and is usually expressed as total corneal refractive power (TCRP). The TCRP is an internal Pentacam ray tracing calculation based on the anterior and posterior corneal radii and the pachymetry according to Snell’s law.
For the 3rd generation formulas, IOL power calculation was based on the sagittal corneal radii (mm) measured by the Pentacam (15°, 3.0-mm ring). The difference between the predicted postoperative residual-refraction (RR) of the IOL determined by ray tracing and the RR of the same IOL obtained using “3rd generation” IOL calculation formulas (namely the SRK-T, Hoffer-Q, Holladay-1, and Haigis formulas) [18,19,20,21], was calculated and analyzed. For each formula we used the author and formula specific recommendation to calculate the effective lens position.
Data management was performed with Microsoft Excel 2010. IBM SPSS® Statistics 22 for Windows (IBM Corporation, Somers, NY, USA) was used for statistical analyses. The normality of the data distribution was tested using the Kolmogorov–Smirnov test and the data did not fit a normal distribution. Wilcoxon signed-rank tests were therefore used to compare differences in the RR obtained with IOL calculation formulas of the 3rd generation (SRK-T, Hoffer-Q, Holladay-1 and Haigis) and that measured by ray tracing, assuming left and right eyes of the same patient to be independent. Data are reported as mean ± standard deviation. The level of statistical significance was set at p ≤ 0.05.
Forty-two eyes of 33 patients (age 68.7 ± 10.1 years; 13 male, 20 female) were included in our study. Different parameters, including patient sex, age, laterality, and IOL power are presented in Table 1.
The mean IOL power calculated by Oculix was 20.4 ± 2.0 D. The difference in RR for the same IOL calculated by Oculix and by the 3rd generation formulas (SRK-T, Hoffer-Q, Holladay-1, and Haigis) was statistically significant (all formulas: p < 0.001). SRK/T formula showed the lowest mean difference in RR compared with Oculix (0.73 ± 0.49 D), while the highest mean difference was found for the Haigis formula (0.90 ± 0.40 D) (Table 2). In most cases, the differences in RR lay between 0.5 D and 1.0 D for all formulas (Table 3).
DMEK is gaining in importance, and with advantages such as reduced immune reactions and impressive visual outcome, it may become the treatment of choice for corneal endothelial disease [2, 3, 5, 6, 12, 22, 23].
DMEK can be performed in patients with clinically significant cataract needing simultaneous cataract surgery and IOL implantation , but can also be carried out in phakic eyes with a clear lens without performing cataract surgery in the same sitting [10, 11]. Given the promise of near complete visual recovery and refractive stability over time with this procedure [7, 22], increasing interest is being focused on IOL power calculations for cataract surgery prior to, in the same setting or after DMEK. In clinical practice, hyperopic outcomes tend to occur after endothelial keratoplasty and in the past many surgeons have aimed to achieve a more myopic postoperative outcome and choose a refractive target of −0.75 to −1.00 D to reduce the chance of unintended hyperopic surprises [8, 11, 24].
Modern two-variable third-generation formulas such as SRK/T, Haigis, Holladay-1 and Hoffer-Q use the corneal power based on the anterior sagittal corneal radii, a fictitious refractive index and axial length for estimation of IOL power . The cornea has two refracting surfaces, and for adequate IOL power calculation the anterior and the posterior corneal surfaces need to be taken into account . Modern optical biometers such as the IOL-Master (Carl Zeiss Meditec, Jena, Germany) do not measure the posterior cornea directly, but instead estimate it using an assumed value for the refractive index of the cornea combined with measurements of the anterior corneal curvature . Ray tracing (considering the anterior and posterior corneal surfaces as well as the pachymetry) achieved a median absolute error of 0.24 D; a considerable improvement of 9% to 14% over already excellent results obtained with classic formulas .
The changed corneal power and the hyperopic shift after triple DMEK have been described in various studies in the literature [7,8,9]. Both Schoenberg et al. and our group showed that the anterior curvature did not significantly change after DMEK [8, 9]. Morphological changes in posterior curvature of the cornea are to be expected after DMEK, because DMEK surgery acts mainly on the backside of the cornea. In contrast to third-generation formulas, the OKULIX ray tracing software uses measured anterior and posterior curvature as well as pachymetry to calculate corneal power.
There are many advantages in performing DMEK in phakic eyes without cataract surgery, including lower risk of retinal detachment and macula edema, retained ability to accommodate in younger FED patients, as well as a more precise lens calculation after postoperative de-swelling of the cornea . However, to obtain this benefit, changes on the posterior surface of the cornea after DMEK must be taken into account. In other words, IOL power calculation should be based, not only on anterior corneal curvature but also on posterior corneal measurements.
This study has several limitations. First, it includes only pseudophakic eyes. Second, changes in corneal thickness were not taken into account. However, the impact of corneal thickness on calculations of corneal power is small . Third, this study is also limited by the small sample size and retrospective design. Further research in a prospective setting with a larger patient population is needed to validate these findings. Studies with patients after phakic DMEK may provide a basis for development of a formula specifically designed for DMEK patients. However, such studies are very difficult to perform, because the number of cataract operations undertaken in patients after phakic DMEK is still low.
In conclusion, this study demonstrates significant differences between IOL power calculations based on measurement of the anterior corneal curvature alone and those based on measurements of anterior and posterior corneal radii as well as pachymetry. These findings are based on overestimated keratometric power due to changes in the anterior/posterior corneal curvature relationship after DMEK. These results need to be taken into account on calculation of IOL power to avoid hyperopic refractive surprises similar to the well-documented hyperopic refractive surprises arising in patients after laser vision correction.
Anterior chamber depth
Descemet membrane endothelial keratoplasty
Descemet stripping automated endothelial keratoplasty
Descemet stripping endothelial keratoplasty
Fuchs endothelial dystrophy
Total corneal refractive power
Lang SJ, Bischoff M, Böhringer D, Seitz B, Reinhard T. Analysis of the changes in keratoplasty indications and preferred techniques. PLoS One. 2014 Nov 11;9(11):e112696.
Ple-Plakon PA, Shtein RM. Trends in corneal transplantation: indications and techniques. Curr Opin Ophthalmol. 2014 Jul;25(4):300–5.
Melles GR, Ong TS, Ververs B, van der Wees J. Preliminary clinical results of Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2008 Feb;145(2):222–7.
Alnawaiseh M, Rosentreter A, Prokosch V, Eveslage M, Eter N, Zumhagen L. Changes in corneal densitometry in patients with Fuchs endothelial dystrophy after endothelial Keratoplasty. Curr Eye Res. 2016 Jun;3:1–5.
Tourtas T, Laaser K, Bachmann BO, Cursiefen C, Kruse FE. Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2012;153(6):1082–90. e2
Anshu A, Price MO, Price FW Jr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology. 2012 Mar;119(3):536–40.
Ham L, Dapena I, Moutsouris K, et al. Refractive change and stability after Descemet membrane endothelial keratoplasty. Effect of corneal dehydration-induced hyperopic shift on intraocular lens power calculation. J Cataract Refract Surg. 2011 Aug;37(8):1455–64.
Schoenberg ED, Price FW Jr, Miller J, McKee Y, Price MO. Refractive outcomes of Descemet membrane endothelial keratoplasty triple procedures (combined with cataract surgery). J Cataract Refract Surg. 2015;41(6):1182–9.
Alnawaiseh M, Rosentreter A, Eter N, Zumhagen L. Changes in corneal refractive power for patients with Fuchs endothelial dystrophy after DMEK. Cornea. 2016 Aug;35(8):1073–7.
Siggel R, Heindl LM, Cursiefen C. Descemet membrane endothelial keratoplasty (DMEK) in phakic eyes with shallow anterior chamber. Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):817–9.
Gundlach E, Maier AK, Tsangaridou MA, Riechardt AI, Brockmann T, Bertelmann E, Joussen AM, Torun N. DMEK in phakic eyes: targeted therapy or highway to cataract surgery? Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):909–14.
Laaser K, Bachmann BO, Horn FK, Cursiefen C, Kruse FE. Descemet membrane endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation: advanced triple procedure. Am J Ophthalmol. 2012;154(1):47–55. e2
Preussner PR, Wahl J, Lahdo H, Dick B, Findl O. Raytracing for intraocular lens calculation. J Cataract Refract Surg. 2002;28(8):1412–9.
Kriechbaum K, Findl O, Preussner PR, Köppl C, Wahl J, Drexler W. Determining postoperative anterior chamber depth. J Cataract Refract Surg. 2003;29(11):2122–6.
Preussner PR, Wahl J, Weitzel D, Berthold S, Kriechbaum K, Findl O. Predicting postoperative intraocular lens position and refraction. J Cataract Refract Surg. 2004;30(10):2077–83.
Preussner PR, Wahl J, Weitzel D. Topography-based intraocular lens power selection. J Cataract Refract Surg. 2005;31(3):525–33.
Preussner PR, Hoffmann P, Petermeier K. Comparison between ray-tracing and IOL calculation formulae of the 3rd generation. Klin Monatsbl Augenheilkd. 2009;226:83–9.
Haigis W, Lege B, Miller N, Schneider B. Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol. 2000;238:765–73.
Hoffer KJ. The Hoffer-Q formula. A comparison of theoretic and regression formulas. J Cataract Refract Surg. 1993;19:700–12. Erratum: J Cataract Refract Surg 1994; 20:677
Holladay JT, Musgrove KH, Prager CT, Lewis JW, Chandler TY, Ruiz RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988;14:17–24.
Retzlaff J, Sanders DR, Kraff MC. Development of the SRK/T intraocularlens implant power calculation formula. J Cat Refract Surg. 1990;16:341–6. erratum J Cat Refract Surg 1990; 16:528
Van Dijk K, Ham L, Tse WH, et al. Near complete visual recovery and refractive stability in modern corneal transplantation: Descemet membrane endothelial keratoplasty (DMEK). Cont Lens Anterior Eye. 2013 Feb;36(1):13–21.
Rodríguez-Calvo-de-Mora M, Quilendrino R, Ham L, Liarakos VS, et al. Clinical outcome of 500 consecutive cases undergoing Descemet's membrane endothelial keratoplasty. Ophthalmology. 2015 Mar;122(3):464–70.
Bonfadini G, Ladas JG, Moreira H, Campos M, Matthaei M, Muñoz B, Pratzer K, Jun AS. Optimization of intraocular lens constant improves refractive outcomes in combined endothelial keratoplasty and cataract surgery. Ophthalmology. 2013;120(2):234–9.
Koch DD, Wang L. Calculating IOL power in eyes that have had refractive surgery. J Cataract Refract Surg. 2003;29:2039–42.
Hoffmann PC, Lindemann CR. Intraocular lens calculation for aspheric intraocular lenses. J Cataract Refract Surg. 2013 Jun;39(6):867–72.
Olsen T. On the calculation of power from curvature of the cornea. Br J Ophthalmol. 1986 Feb;70(2):152–4.
There are no acknowledgements to note.
There are no funding bodies to report for this submission.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the University of Muenster, North Rhine Westphalia, Germany and was performed according to the tenets of the Declaration of Helsinki. This study is a retroactive review of patient data; therefore consent was not collected from participants.
Consent for publication
Dr. Zumhagen reports personal fees for lectures from Oculus Optikgeräte GmbH, Germany.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Alnawaiseh, M., Zumhagen, L., Rosentreter, A. et al. Intraocular lens power calculation using standard formulas and ray tracing after DMEK in patients with Fuchs endothelial dystrophy. BMC Ophthalmol 17, 152 (2017). https://doi.org/10.1186/s12886-017-0547-7
- Intraocular lens power calculation
- Ray tracing